GSK’s CEO Emma Walmsley To Step Down

Luke Miels will take over from Walmsley on January 1, GSK said in a statement.

By Channels Television

Updated September 29, 2025

In this file photo taken on July 29, 2013, the headquarters of the British pharmaceutical company GlaxoSmithKline (GSK) is pictured in west London. Ben STANSALL / AFP

British pharmaceutical giant GSK on Monday said chief executive Emma Walmsley will step down after nearly nine years at the helm, to be replaced by its chief commercial officer.

Luke Miels will take over from Walmsley on January 1, GSK said in a statement.

Earlier this month, GSK said it planned to invest $30 billion in the United States over the next five years, ahead of US President Donald Trump’s announcement last week that new tariffs will hit the pharmaceutical industry starting Wednesday.

AFP